We are live on ! Find out more
ELTX icon

Elicio Therapeutics
ELTX

47 hedge funds and large institutions have $69.3M invested in Elicio Therapeutics in 2021 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 22 increasing their positions, 4 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

450% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 4

75% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 8

15% more funds holding

Funds holding: 41 → 47 (+6)

4% more capital invested

Capital invested by funds: $66.5M → $69.3M (+$2.81M)

0.68% more ownership

Funds ownership: 1.7% → 2.38% (+0.68%)

Holders
47
Holders Change
+6
Holders Change %
+14.63%
% of All Funds
0.82%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
22
Reduced
4
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$7.96M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$7.01M
3
Russell Investments Group
Russell Investments Group
United Kingdom
+$2.68M
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$1.63M
5
Northern Trust
Northern Trust
Illinois
+$1.23M

Top Sellers

Rank Fund Capital Flow
1
HF
HRT Financial
New York
-$779K
2
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$744K
3
Millennium Management
Millennium Management
New York
-$626K
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$420K
5
JP Morgan Chase
JP Morgan Chase
New York
-$396K
Name Holding Trade Value Shares
Change 		Change in
Stake
BI
1
BVF Inc
California
$10.5M +$376K +3,480 +3%
PWAM
2
Park West Asset Management
California
$10.2M +$383K +3,549 +4%
BlackRock
3
BlackRock
New York
$9.95M +$7.96M +73,683 +262%
Vanguard Group
4
Vanguard Group
Pennsylvania
$8.8M +$7.01M +64,876 +257%
Franklin Resources
5
Franklin Resources
California
$6.01M +$2.81K +26 +0%
Fidelity Investments
6
Fidelity Investments
Massachusetts
$3.05M – – –
SCM
7
Stonepine Capital Management
Oregon
$2.74M +$620K +5,734 +26%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$2.46M +$1.63M +15,043 +149%
Russell Investments Group
9
Russell Investments Group
United Kingdom
$2.42M +$2.68M +24,809 New
Northern Trust
10
Northern Trust
Illinois
$1.74M +$1.23M +11,379 +176%
State Street
11
State Street
Massachusetts
$1.56M +$804K +7,446 +87%
JP Morgan Chase
12
JP Morgan Chase
New York
$1.47M -$396K -3,662 -20%
NCM
13
Nantahala Capital Management
Connecticut
$1.16M -$70K -648 -5%
CM
14
CM Management
Florida
$916K – – –
Victory Capital Management
15
Victory Capital Management
Texas
$751K -$6.7K -62 -0.8%
KCM
16
Knoll Capital Management
Florida
$586K – – –
BBA
17
BLB&B Advisors
Pennsylvania
$555K – – –
BC
18
Birchview Capital
Vermont
$531K -$67.3K -623 -10%
Charles Schwab
19
Charles Schwab
California
$448K +$135K +1,254 +38%
Bank of New York Mellon
20
Bank of New York Mellon
New York
$409K +$453K +4,189 New
Morgan Stanley
21
Morgan Stanley
New York
$385K +$130K +1,205 +44%
VFA
22
Valeo Financial Advisors
Indiana
$365K +$404K +3,740 New
SO
23
STRS Ohio
Ohio
$346K – – –
Nuveen
24
Nuveen
North Carolina
$338K +$347K +3,214 New
Bank of America
25
Bank of America
North Carolina
$287K +$219K +2,025 +222%
1
2 3

ELTX Hedge Fund Activity: Q3 2021 in Review

47 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Elicio Therapeutics (ELTX) for Q3 2021, worth a combined $69.3M — up 4.2% from $66.5M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new ELTX positions and 8 closed out — a net gain of 6 holders — while 22 added to existing stakes and 4 trimmed.

The largest buyer was BlackRock, adding an estimated $7.96M. The largest seller was HRT Financial, exiting entirely with an estimated $779K sold.

  • 47 institutional investors held Elicio Therapeutics (ELTX) as of Q3 2021, up from 41 in Q2 2021.
  • Funds reported $69.3M of Elicio Therapeutics stock for Q3 2021, up 4.2% quarter-over-quarter.
  • 14 funds opened new Elicio Therapeutics positions in Q3 2021 and 8 closed out, a net change of +6 holders.
  • The largest Elicio Therapeutics buyer in Q3 2021 was BlackRock, an estimated $7.96M added.
  • The largest Elicio Therapeutics seller in Q3 2021 was HRT Financial, an estimated $779K sold.

Based on aggregated 13F filings for Q3 2021.